SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-027989
Filing Date
2023-08-08
Accepted
2023-08-08 08:53:39
Documents
73
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20230630.htm   iXBRL 10-Q 1345771
2 EX-10.1 a101inducementrsu-april202.htm EX-10.1 33892
3 EX-10.2 a1022017planrsuagreement.htm EX-10.2 36582
4 EX-10.3 a103directorrsuagreement-a.htm EX-10.3 18356
5 EX-31.1 exhibit31110-qfy2023q2.htm EX-31.1 11102
6 EX-31.2 exhibit31210-qfy2023q2.htm EX-31.2 11066
7 EX-32.1 exhibit32110-qfy2023q2.htm EX-32.1 5695
  Complete submission text file 0001628280-23-027989.txt   6021932

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrsn-20230630.xsd EX-101.SCH 39859
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrsn-20230630_cal.xml EX-101.CAL 47991
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrsn-20230630_def.xml EX-101.DEF 202237
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrsn-20230630_lab.xml EX-101.LAB 488334
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrsn-20230630_pre.xml EX-101.PRE 343705
67 EXTRACTED XBRL INSTANCE DOCUMENT mrsn-20230630_htm.xml XML 716263
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 231149526
SIC: 2834 Pharmaceutical Preparations